Filed: Mar 17, 1995

Published: Aug 07, 2001

Abstract

The invention relates to novel human DNA sequences, targeting constructs, and methods for producing novel genes encoding thrombopoietin, DNase I, and beta-interferon by homologous recombination. The targeting constructs comprise at least: a) a targeting sequence; b) a regulatory sequence; c) an exon; and d) a splice-donor site. The targeting constructs, which can undergo homologous recombination with endogenous cellular sequences to generate a novel gene, are introduced into cells to produce homologously recombinant cells. The homologously recombinant cells are then maintained under conditions which will permit transcription of the novel gene and translation of the mRNA produced, resulting in production of either thrombopoietin, DNase I, or beta-interferon. The invention further relates to a methods of producing pharmaceutically useful preparations containing thrombopoietin, DNase I, or beta-interferon from homologously recombinant cells and methods of gene therapy comprising administering homologously recombinant cells producing thrombopoietin, DNase I, or beta-interferon to a patient for therapeutic purposes.

Family Members

Classification Codes

A61K48/00, C07K14/435, C07K14/565, C07K14/605, C12N15/85, C07K14/61, C12N15/90, C12N15/87, A61K38/00, C07K14/52, C12N15/67, C07K14/505, C12N9/16